Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study

The Lancet Global Health

Volumn 5, Issue 1, 2017, Pages e80-e88

  Sissoko, Daouda ^a,b   Duraffour, Sophie ^c,d   Kerber, Romy ^d,e   Kolie, Jacques Seraphin ^f   Beavogui, Abdoul Habib ^f   Camara, Alseny Modet ^g   Colin, Géraldine ^a,h   Rieger, Toni ^d,e   Oestereich, Lisa ^d,e   Pályi, Bernadett ⁱ   Wurr, Stephanie ^d,e   Guedj, Jeremie ^j   Nguyen, Thi Huyen Tram ^j   Eggo, Rosalind M ^k   Watson, Conall H ^k   Edmunds, W John ^k   Bore, Joseph Akoi ^c,l   Koundouno, Fara Raymond ^c,l   Cabeza Cabrerizo, Mar ^c,d   Carter, Lisa L ^c,m   Kafetzopoulou, Liana Eleni ^c,n   Kuisma, Eeva ^c,o   Michel, Janine ^c,p   Patrono, Livia Victoria ^c,d   Rickett, Natasha Y ^c,q   Singethan, Katrin ^c,r   Rudolf, Martin ^d,e   Lander, Angelika ^p   Pallasch, Elisa ^d,e   Bockholt, Sabrina ^d,e   Rodríguez, Estefanía ^e,s   Di Caro, Antonino ^c,t   Wölfel, Roman ^c,u   Gabriel, Martin ^c,d   Gurry, Céline ^v   Formenty, Pierre ^v   Keïta, Sakoba ^l   Malvy, Denis ^a,b   Carroll, Miles W ^c,o,w   Anglaret, Xavier ^a,h   Günther, Stephan ^c,d,e   more..

^a UNIVERSITÉ DE BORDEAUX   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c European Mobile Laboratory Consortium   (Germany)

^d BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^e German Centre for Infection Research (DZIF)   (Guinea)

^f Centre de Formation et de Recherche en Santé Rurale de Maferinyah   (Guinea)

^g Department of Haematology   (Guinea)

^h University Hospital of Treichville   (Côte d’Ivoire)

ⁱ NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

^j INSERM   (France)

^k LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^l Ministry of Health Guinea   (Guinea)

^m UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁿ REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^o PUBLIC HEALTH ENGLAND   (United Kingdom)

^p ROBERT KOCH INSTITUTE   (Germany)

^q UNIVERSITY OF LIVERPOOL   (United Kingdom)

^r TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^s LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^t NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^u Bundeswehr Institute of Microbiology   (Switzerland)

^v WORLD HEALTH ORGANIZATION   (Switzerland)

^w UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA; RNA;

ADOLESCENT; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LONGITUDINAL STUDY; MALE; MATHEMATICAL MODEL; MIDDLE AGED; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEMINAL PLASMA; VIRUS REPLICATION; GENETICS; GUINEA; ISOLATION AND PURIFICATION; SPERM; STATISTICAL MODEL; SURVIVOR; TIME FACTOR; TRANSMISSION; VIROLOGY;

ADULT; EBOLAVIRUS; GUINEA; HEMORRHAGIC FEVER, EBOLA; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MODELS, STATISTICAL; RNA; SEMEN; SURVIVORS; TIME FACTORS;

EID: 85003441798     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(16)30243-1     Document Type: Article

References (26)

1. 1 WHO. Ebola data and statistics. http://apps.who.int/gho/data/node.ebola-sitrep (accessed Jan 19, 2016).
2. 2 WHO. Latest Ebola outbreak over in Liberia; West Africa is at zero, but new flare-ups are likely to occur. http://www.who.int/mediacentre/news/releases/2016/ebola-zero-liberia/en/ (accessed Sept 4, 2016).
3. 3 WHO. Sexual and reproductive health, Interim advice on the sexual transmission of the Ebola virus disease, updated January, 2016. http://www.who.int/reproductivehealth/topics/rtis/ebola-virus-semen/en/ (accessed Jan 19, 2016 ).
4. 4 Thorson, A, Formenty, P, Lofthouse, C, Broutet, N, Systematic review of the literature on viral persistence and sexual transmission from recovered Ebola survivors: evidence and recommendations. BMJ Open, 6, 2016, e008859.
5. 5 Martini, GA, Schmidt, HA, [Spermatogenic transmission of the “Marburg virus”. (Causes of “Marburg simian disease”)]. Klin Wochenschr 46 (1968), 398–400 (in German).
6. 6 Emond, RT, Evans, B, Bowen, ET, Lloyd, G, A case of Ebola virus infection. Br Med J 2 (1977), 541–544.
7. 7 Rodriguez, LL, De Roo, A, Guimard, Y, et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 179:suppl 1 (1999), S170–S176.
8. 8 Rowe, AK, Bertolli, J, Khan, AS, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 179:suppl 1 (1999), S28–S35.
9. 9 Bausch, DG, Towner, JS, Dowell, SF, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 196:suppl 2 (2007), S142–S147.
10. 10 Christie, A, Davies-Wayne, GJ, Cordier-Lasalle, T, et al. Possible sexual transmission of Ebola virus - Liberia, 2015. MMWR Morb Mortal Wkly Rep 64 (2015), 479–481.
11. 11 Mate, SE, Kugelman, JR, Nyenswah, TG, et al. molecular evidence of sexual transmission of Ebola virus. N Engl J Med 373 (2015), 2448–2454.
12. 12 Deen, GF, Knust, B, Broutet, N, et al. Ebola RNA persistence in semen of Ebola virus disease survivorspreliminary report. N Engl J Med, 2015 published online Oct 14. http://dx.doi.org/10.1056/NEJMoa1511410.
13. 13 Sissoko, D, Laouenan, C, Folkesson, E, et al. Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea. PLoS Med, 13, 2016, e1001967.
14. 14 Rieger, T, Kerber, R, El Halas, H, et al. Evaluation of RealStar reverse transcription-polymerase chain reaction kits for filovirus detection in the laboratory and field. J Infect Dis 214:suppl 3 (2016), S243–S249.
15. 15 Kuhn, E, Lavielle, M, Maximum likelihood estimation in nonlinear mixed effects models. Com Stat Data Anal 49 (2005), 1020–1038.
16. 16 Thiebaut, R, Guedj, J, Jacqmin-Gadda, H, et al. Estimation of dynamical model parameters taking into account undetectable marker values. BMC Med Res Methodol, 6, 2006, 38.
17. 17 Eggo, RM, Watson, CH, Camacho, A, Kucharski, AJ, Funk, S, Edmunds, WJ, Duration of Ebola virus RNA persistence in semen of survivors: population-level estimates and projections. Euro Surveill, 20, 2015 pii=30083.
18. 18 WHO Ebola Response Team. Ebola virus disease in West Africa the first 9 months of the epidemic and forward projections. N Engl J Med 371 (2014), 1481–1495.
19. 19 Soka, MJ, Choi, MJ, Baller, A, et al. Prevention of sexual transmission of Ebola in Liberia through a national semen testing and counselling programme for survivors: an analysis of Ebola virus RNA results and behavioural data. Lancet Glob Health 10 (2016), e736–e743.
20. 20 Diallo, B, Sissoko, D, Loman, NJ, et al. Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days. Clin Infect Dis 63 (2016), 1353–1356.
21. 21 Caluwaerts, S, Fautsch, T, Lagrou, D, et al. Dilemmas in managing pregnant women with Ebola: 2 case reports. Clin Infect Dis 62 (2016), 903–905.
22. 22 Kibadi, K, Mupapa, K, Kuvula, K, et al. Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis 179:suppl 1 (1999), S13–S14.
23. 23 Varkey, JB, Shantha, JG, Crozier, I, et al. Persistence of Ebola virus in ocular fluid during convalescence. N Engl J Med 372 (2015), 2423–2427.
24. 24 Howlett, P, Brown, C, Helderman, T, et al. Ebola virus disease complicated by late-onset encephalitis and polyarthritis, Sierra Leone. Emerg Infect Dis 22 (2016), 150–152.
25. 25 Formenty, P, Leroy, EM, Epelboin, A, et al. Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis 42 (2006), 1521–1526.
26. 26 Kreuels, B, Wichmann, D, Emmerich, P, et al. A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med 371 (2015), 2394–2401.